Kailera Therapeutics IPO Priced at $16 Per Share
Kailera Therapeutics (KLRA) priced its IPO at $16 per share, raising $624.96 million through the sale of 39.06 million shares. The pricing was at the high end of the expected $14 to $16 range, with the deal size increased from 33.3 million shares. The company focuses on obesity care and is backed by several major investment banks.
Topics: biotechnology investment IPO Kailera Therapeutics stock market